OverviewSuggest Edit

ProtoKinetix is a bio-technology company that provides medical researchers with a platform for enhancing cell survival and health, both in vitro and in vivo. At the heart of its technology is its patented anti-aging glycopeptide AAGP. This small molecule (580 Daltons) displays abilities in resolving challenges confronting medical researchers in such areas as regenerative medicine and as a therapy for diseases relating to tissue inflammation and oxidation stress. Because of its stability, small size and molecular makeup, it maintains its function in vivo without triggering the body's immune system. Further, it can function without toxic side effects common in treatments involving larger and less stable compounds.

TypePublic
Founded1999
HQMarietta, US
Websiteprotokinetix.com

Locations

ProtoKinetix is headquartered in
Marietta, United States

Location Map

Latest Updates

Share Price (Oct 2017)$0.1

Key People/Management at ProtoKinetix

Clarence E. Smith

Clarence E. Smith

Chairman, President, Directo
Edward P. McDonough

Edward P. McDonough

CPA Director
Michael R. Guzzetta

Michael R. Guzzetta

MBA, CPA Chief Financial Officer
Julia Levy

Julia Levy

PhD Chairman, Business and Scientific Advisory Board
Show more

ProtoKinetix Office Locations

ProtoKinetix has an office in Marietta
Marietta, US (HQ)
412 Mulberry St
Show all (1)

ProtoKinetix Financials and Metrics

ProtoKinetix Revenue

USD

Market capitalization (8-Oct-2018)

27.9m

Cash (30-Jun-2019)

503.8k
ProtoKinetix's current market capitalization is $27.9 m.
USDQ2, 2014Q3, 2014

General and administrative expense

49.0k21.0k

R&D expense

2.1k

Operating expense total

49.0k23.1k
Annual
USDFY, 2012FY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Cash

2.4k3.1k371.1k371.0k302.9k136.0k

Accounts Receivable

6.0k119.0

Current Assets

379.5k441.4k365.1k137.1k

Total Assets

449.8k542.1k518.1k324.9k
Quarterly
USDQ1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

13.9k4.5k2.5k1.7k6.8k10.9k130.7k114.4k163.5k261.0k108.5k89.0k549.2k238.3k386.1k192.1k214.4k110.5k24.1k503.8k

Accounts Receivable

6.0k119.01.3k2.2k5.9k7.9k8.0k8.0k8.0k

Current Assets

123.2k172.1k269.2k271.1k180.4k575.1k380.8k483.9k250.8k276.9k121.6k45.9k549.4k

Total Assets

168.0k188.2k237.1k340.6k346.4k256.0k718.3k532.0k637.6k406.0k438.0k300.3k234.8k742.1k
Annual
USDFY, 2012FY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Accounts Payable

28.0k82.6k(18.2k)(3.7k)(14.8k)49.7k

Cash From Operating Activities

(149.9k)(105.3k)(574.2k)(820.3k)(605.1k)(453.5k)

Cash From Investing Activities

25.0k(46.8k)(29.8k)57.0k(35.5k)

Cash From Financing Activities

81.0k991.8k850.0k480.0k322.0k
USDY, 2019

Financial Leverage

1 x
Show all financial metrics

ProtoKinetix Online and Social Media Presence

Embed Graph

ProtoKinetix Frequently Asked Questions

  • When was ProtoKinetix founded?

    ProtoKinetix was founded in 1999.

  • Who are ProtoKinetix key executives?

    ProtoKinetix's key executives are Clarence E. Smith, Edward P. McDonough and Michael R. Guzzetta.

  • Who are ProtoKinetix competitors?

    Competitors of ProtoKinetix include International Stem Cell Corporation, PacifiCord and Clementia Pharmaceuticals.

  • Where is ProtoKinetix headquarters?

    ProtoKinetix headquarters is located at 412 Mulberry St, Marietta.

  • Where are ProtoKinetix offices?

    ProtoKinetix has an office in Marietta.

  • How many offices does ProtoKinetix have?

    ProtoKinetix has 1 office.